GDUFA And BsUFA Fees Set To Leap

US FDA Corrects Errors, Limits PDUFA Application Fee Increase

error
The FDA did not account for fee refunds and waivers in its FY 2023 and FY 2024 FAE calculations • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Generics

More from Products